Lee Troy Schalop, Director at Lantern Pharma Inc. (LTRN), bought 48,544 shares at $2.06 ($100K) on 2026-05-12, disclosed to the SEC on 2026-05-14.
Director Lee Troy Schalop purchased 48,544 shares at $2.06 on May 12, 2026, marking the largest insider purchase in the company's history. This significant accumulation by a director suggests confidence in the company's long-term prospects amidst recent volatility.
The stock has rallied significantly over the past month, gaining 32.55% in the last 30 days to reach $3.095, though it remains 46.12% below its 52-week high of $5.74.
Something here stands out, but not much.